Skip to main content

Should your startup file a patent? The business case beyond legal protection

Updated 9 min readMarkdown
Should your startup file a patent? The business case beyond legal protection

Patents are usually discussed as legal tools for preventing competitors from copying inventions. For startups, their commercial value can extend considerably further, but only when patent protection supports a credible business strategy.

For an early-stage startup, filing a patent can feel like an expensive commitment to an uncertain future. The company may still be developing its technology, testing customer demand or attempting to raise its first round of investment.

Patent attorneys understandably emphasise the legal benefits of protecting an invention, particularly the ability to prevent competitors from exploiting technology covered by a granted patent. But the business case for filing a patent extends beyond the prospect of enforcing those rights in court.

A patent application can influence fundraising, commercial negotiations, market positioning, and a business's strategic options. The more important question is whether those benefits justify the cost and commitments involved.

A patent can make an investment proposition more compelling.

Investors are not simply purchasing an interest in an interesting idea. They assess whether a company can establish and maintain a competitive advantage that generates attractive financial returns.

For technology businesses, patents may contribute to that advantage by creating legal barriers to imitation, supporting licensing opportunities and establishing rights that can be transferred or sold. A patent portfolio can also demonstrate that the founders have considered how their technology will be protected as the business grows.

This can be particularly important for businesses developing medical devices, advanced manufacturing technologies, or other inventions that require substantial capital before commercial revenues materialise. Where product development is expensive, and competitors could otherwise replicate the underlying technology relatively easily, meaningful patent protection may improve the investment proposition.

But it would be a mistake to assume that investors automatically favour companies with patents.

A patent is evidence of a potential competitive advantage, not proof of a commercially successful business. Investors still need to understand the market opportunity, customer demand, technological feasibility and the company's ability to execute its business plan.

A narrowly drafted patent covering an incidental product feature may offer little commercial protection. Conversely, a company with no registered patents may possess substantial competitive advantages through proprietary data, confidential know-how, network effects or customer relationships.

The quality and commercial relevance of the patent matter considerably more than the number of applications filed.

Filing a patent can create value before the patent is granted.

Obtaining a patent is not instantaneous. Examination, objections and other procedural requirements can mean that several years pass between an initial application and the grant of enforceable rights.

Nevertheless, filing can establish an important priority date and give the company a basis for developing a longer-term patent strategy. A properly prepared Australian provisional application generally provides 12 months in which to pursue a corresponding complete application while preserving the earlier priority date for subject matter adequately disclosed in the provisional filing.

That period can be commercially valuable. Founders may use it to engage investors, develop prototypes, investigate overseas markets and assess whether the invention justifies further investment.

However, a provisional application does not itself confer enforceable patent rights, and filing an application does not guarantee that a patent will ultimately be granted. The commercial benefit therefore lies in preserving an opportunity to obtain protection, rather than securing exclusivity immediately.

Patents can also influence how a business is perceived in the market.

A legitimate patent-pending designation may signal that a company has taken formal steps to protect its invention. For certain products, particularly where technical differentiation matters commercially, this can support conversations with customers, distributors, and strategic partners.

It may also cause competitors to examine the technology more carefully before developing a competing product, especially where the eventual scope of the patent claims remains uncertain.

But this signalling benefit should not be overstated.

A patent application has not necessarily been examined, and its claims may ultimately be refused or substantially narrowed. Customers and sophisticated investors should not treat patent-pending status as independent verification of technical quality, novelty or commercial value.

The strongest market positioning therefore comes from connecting the patent strategy to a genuine product advantage, rather than relying on the existence of an application as a marketing credential.

Patent rights can strengthen a startup's negotiating position.

The most interesting commercial benefit of patent protection often arises when a smaller company must negotiate with a much larger organisation.

A startup developing a valuable technology may lack the manufacturing capacity, distribution networks or financial resources necessary to commercialise it independently. An established business may possess those resources but need access to the startup's technology.

Patent rights can provide a foundation for negotiating licensing agreements, joint development arrangements, strategic investments or an eventual acquisition.

Rather than selling the business or surrendering control over its technology, the startup may grant a commercial partner carefully defined rights in exchange for royalties, milestone payments, or other consideration.

This creates opportunities to structure transactions around particular territories, applications or fields of use. A business might license its technology for one industry while retaining the ability to commercialise it independently in another.

In markets where companies possess overlapping patent portfolios, patents may also provide leverage in cross-licensing negotiations. A party with relevant rights may be better positioned to negotiate reciprocal access rather than simply accepting another company's licensing demands.

However, negotiating leverage depends on the actual strength and relevance of the rights being asserted. A patent that is vulnerable to challenge, easy to design around or commercially irrelevant to the counterparty may provide little practical advantage.

Resources also matter. A small company might own valuable patent rights but lack the financial capacity to enforce them against a well-funded competitor, which can materially affect its negotiating position.

A patent does not eliminate the need for commercial judgment.

Patent protection involves a trade-off. In exchange for a time-limited exclusive right, the applicant must disclose the invention sufficiently to satisfy the relevant legal requirements.

Once published, the disclosed technical information generally becomes publicly accessible, even if the application is subsequently refused or the resulting patent offers less protection than anticipated.

For some businesses, particularly those relying on manufacturing processes or technical information competitors cannot readily discover, maintaining trade secrets may be a better strategy. For others, patent protection may be essential because competitors can reverse-engineer the invention once the product enters the market.

Geography also matters. An Australian patent protects the invention in Australia, not automatically in every country where the company may eventually operate.

A business anticipating international expansion must consider where protection is commercially valuable and whether the potential returns justify the considerable costs of obtaining and maintaining rights across multiple jurisdictions.

Importantly, owning a patent does not necessarily mean the company can commercialise the invention. Earlier patents held by third parties may still restrict the company's intended activities, so freedom-to-operate analysis is a separate, important consideration.

The financial question is not simply whether the startup can afford to file.

According to IP Australia's published fee schedule, the official filing fee for an Australian provisional patent application starts at $100. However, IP Australia indicates that professional preparation and filing can cost approximately $3,000 to $8,000, with additional costs for complete applications, examination, and international protection.

For an early-stage startup, these costs must compete with other pressing capital demands. Product development, regulatory approvals, hiring and customer acquisition may each have a more immediate effect on the company's prospects.

The decision to file should therefore be informed by the commercial significance of the invention, the likelihood of obtaining meaningful protection and the value of preserving future options.

A sensible patent strategy may involve protecting a small number of commercially important inventions while declining to patent other developments. It may also involve making staged investment decisions as technical feasibility, market demand and funding prospects become clearer.

The relevant question is not whether patents are inherently worth the expense, but whether a particular patent is likely to improve the company's commercial position sufficiently to justify its total cost.

A patent should support the business model, not become the business model.

One risk for technology founders is becoming so focused on the invention that they overlook the commercial problem it is supposed to solve.

A startup may possess technically impressive intellectual property without having established a sufficiently attractive market, viable pricing model or effective route to customers. Patent protection cannot compensate for those weaknesses.

Equally, a startup that understands its market but fails to secure commercially important intellectual property rights may be exposed when competitors enter the market, or prospective investors examine the company's ownership arrangements.

The objective is to align intellectual property protection with the company's broader commercial strategy.

That requires understanding which aspects of the technology create value, whether competitors can reproduce those advantages, what legal rights the company needs to control and how its intellectual property might support future transactions.

The real business case for filing a patent is about preserving commercial options.

A patent may help a startup attract investment, establish credibility, negotiate with commercial partners, generate licensing revenue or protect its market position. These benefits can arise at different stages of the company's development, and some may become commercially relevant well before any infringement dispute arises.

But none is automatic, and a patent application should never be confused with a guarantee of exclusivity or commercial success.

For founders, the decision to file should start with an assessment of the company's business model, not the assumption that every invention deserves patent protection.

The question is not simply, "Can we patent this technology?"

It is "If we obtain meaningful patent protection, how will that change our ability to attract capital, negotiate with partners, compete in the market or create value?"

If the answer is compelling, filing a patent may be one of the most strategically valuable investments an early-stage business can make. If the answer is unclear, a better investment may be understanding the market, refining the technology, or identifying what makes the business difficult to replicate.

About the author

  • I am a legal counsel and IP specialist with technology expertise in software, machine learning and Web3 technologies. I also have extensive experience with medical devices and mechanical devices.

No comments yet. Be the first to comment.